Before enrolling with LongevityRx, the most useful question is not simply whether you qualify. It is whether you can get a clear, written account of what happens after approval: who treats you, which pharmacy supplies the medication, what each charge purchases and how you stop future charges. The advertised starting prices are concrete enough to compare, but the cancellation language is not consistent across the consulted pages. That difference matters when a program combines recurring payments with prescription fulfillment.
This documentary review examines LongevityRx’s public pages consulted October 19, 2026. The site advertises compounded injectable semaglutide and tirzepatide, a GLP-1 Microdose program and other longevity-oriented therapies. It describes online assessment, clinician review, home delivery and follow-up, while its terms separate the website operator from independent clinical and pharmacy services. The questions below focus on those documented arrangements—not firsthand treatment, verified credentials or assumed results—and identify what a prospective patient should resolve before sharing payment information.
At a glance
- Advertised injectable prices
- Semaglutide injection starts at $149/month and tirzepatide injection at $169/month. The site conditions starting pricing on provider review; supply quantities and the duration of these prices are not established.Sources: [4]
- Recurring billing
- The terms authorize an immediate charge for recurring monthly orders, then another every 30 days until cancellation, with electronic notice five to seven days before a scheduled transaction.Sources: [6]
- Conflicting cancellation deadlines
- Treatment FAQs require 30 days’ notice before the next billing cycle; the terms permit disabling auto-refill up to 48 hours before monthly processing.
- Separate service responsibilities
- Cal Choice Family Practice, Inc owns and operates the website but says it does not provide clinical care or prepare or dispense medication.Sources: [6]
- Pharmacy restriction
- The terms require prescriptions purchased through the service to be filled through a platform-accessible pharmacy rather than a pharmacy chosen by the patient.Sources: [6]
What will the first payment actually buy?
LongevityRx’s homepage lists semaglutide injection from $149 per month and tirzepatide injection from $169 per month. Each listing includes an online provider visit, prescription, discreet home delivery and ongoing care and check-ins. The same displays also show $249 and $299, respectively, without explaining their commercial role in the consulted text. Do not assume those higher figures are renewal prices, former prices or the price of a particular medication quantity.
The homepage calls pricing an educational estimate, confirmed after provider review. Treatment pages separately advertise flat-rate pricing with no hidden fees, consultation charges or dose-change surcharges. The terms describe a bundled amount covering the pharmacy’s prescription-drug fee, the medical group’s clinical-services fee and platform access. These statements give the offer some definition, but they do not establish how much medication arrives per payment or whether laboratory work is required and included.
Ask for the approved product, presentation, quantity, billing interval and all included services in one written quote. The site advertises “No insurance,” but that is not a complete policy on reimbursement, government-insurance eligibility or HSA/FSA use. No financing or prepayment arrangement is established in the reviewed documentation. Our guide to price questions beyond the monthly figure can help organize the details that remain unresolved.
| Topic | What LongevityRx documents | What to confirm |
|---|---|---|
| Semaglutide injection | From $149/month; $249 also displayed | Your approved price, quantity and meaning of $249 |
| Tirzepatide injection | From $169/month; $299 also displayed | Your approved price, quantity and meaning of $299 |
| Bundled services | Drug, clinical services and platform access | Whether labs or other required services cost extra |
| Recurring order | Immediate charge, then every 30 days | First charge date and subsequent processing dates |
| Not approved | Advertises $0 if not approved | When approval and payment authorization occur |
Which cancellation rule will govern your account?
The clearest reason to pause before payment is the mismatch between two cancellation statements. Treatment FAQs say memberships may be canceled with 30 days’ notice before the next billing cycle. The terms instead allow cancellation by switching off auto-refill in the user portal up to 48 hours before monthly processing. Those are materially different deadlines. The reviewed documentation does not explain whether they apply to different products or which controls when they conflict.
For recurring monthly orders, the terms authorize a charge immediately and every 30 days afterward until cancellation. That is a 30-day billing interval, not necessarily the same date each calendar month. Electronic transaction notices are promised five to seven days beforehand, followed by receipts after successful charges. Under the treatment FAQ’s longer deadline, a reminder arriving that late would not provide enough notice to avoid the next cycle.
Request written confirmation of the applicable deadline, the action required and how cancellation is acknowledged. Treatment pages say consultations, medical visits and fulfilled prescriptions become nonrefundable once services begin or medication is processed. Stopping future renewal therefore does not establish a right to recover an earlier payment. Save the applicable terms and cancellation confirmation; the questions to settle before renewal provide a useful checklist for this particular uncertainty.
Who will be responsible for your care?
The site’s treatment pages describe LongevityRx as a physician-led practice powered by board-certified physicians and licensed clinicians. Its disclaimer calls it a concierge telehealth platform connecting patients with independent, U.S. board-certified clinical providers and state-licensed compounding pharmacies. Those are provider assertions, not credentials independently verified for this review. The consulted documentation does not name the treating professionals, their medical groups or the partner pharmacies.
The terms identify Cal Choice Family Practice, Inc as the website’s owner and operator, while explicitly stating that it does not practice medicine, provide clinical care, prepare or dispense medication, or control professional judgment. That contractual separation matters more than the branding when you need a prescription clarification, a clinical decision or a medication replacement. Ask which medical entity accepts responsibility for treatment and which entity handles administrative complaints.
Enrollment starts with a short online assessment covering health goals and basic medical history. A licensed clinician reviews it and, when clinically appropriate, develops a plan and coordinates care. The site promises no guaranteed treatment and advertises no obligation and $0 if approval is denied. Ask when you receive the clinician’s identity, whether a live consultation is involved and when payment is authorized; the public description does not establish every step or review time.
What medicine is proposed, and why that formulation?
The treatment pages describe compounded medication prepared by partner compounding pharmacies and shipped on a structured cadence. The homepage says customized formulations may be prescribed when commercially available treatments do not meet a patient’s individual needs. It also states that compounded medications are not FDA approved. Ask for the proposed active ingredient, formulation, injectable presentation and dispensing pharmacy before treating the advertised drug name as a complete product description.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. These preparations do not undergo FDA premarket review for safety, effectiveness and quality. That distinction does not, by itself, prove clinical inequivalence or establish that a particular provider is appropriate or inappropriate. It does make the clinical rationale and exact prescription important questions rather than details to defer until delivery.
The separately marketed GLP-1 Microdose program is described as a lower-dose protocol for metabolic health, body composition and appetite recalibration, not aggressive weight loss. It advertises candidates near their goal weight and people who poorly tolerated standard protocols. The reviewed pages do not establish its active ingredient or route, and those marketing descriptions do not demonstrate benefits. LongevityRx also promotes compounded peptides for recovery, metabolism, longevity and focus. Use the medication-identification questions before comparing any of these offers.
Do the advertised screening criteria apply to you?
LongevityRx’s semaglutide page advertises adults 18 or older with a BMI of at least 27, or at least 25 with weight-related conditions. These are the provider’s published screening criteria, not a conclusion that a reader qualifies for treatment. Its listed exclusions include personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy, breastfeeding or pregnancy plans, active pancreatitis, and untreated severe gastrointestinal disease. A clinician must evaluate the relevant history.
The tirzepatide page also describes patients who have plateaued on a single-agonist GLP-1 and want a supervised change. This is a description of the marketed program, not evidence that switching is appropriate for an individual. NIDDK advises discussing current conditions, other medicines, supplements, allergies and pregnancy plans with the treating clinician. Its general adult medication thresholds are BMI 30 or higher, or 27 or higher with weight-related health problems; thresholds alone never establish eligibility.
Location requires a separate check. Although the homepage advertises nationwide telehealth, the terms restrict service to states where the company operates. Patients must be at least 18—or the local age of majority if higher—and physically in the same state as their account’s shipping address during consultation. No complete state-by-state or product-specific availability list was established. Ask about your actual location, especially if you travel, before assuming a mailing address is sufficient.
Which pharmacy ships it, and what happens if delivery fails?
The terms say an approved prescription will be filled through one of the pharmacies accessible through the platform. Purchasing a prescription-inclusive service requires accepting that channel rather than choosing another pharmacy. The applicable pharmacy ships directly to the patient, but the consulted documentation does not identify it by name. Before enrolling, request its identity and contact information, and ask which organization handles dispensing questions, replacement decisions and problems with the contents of a shipment.
Treatment pages advertise temperature-controlled, unmarked packaging, while the homepage promotes free two-to-three-day shipping. That shipping claim does not establish the total time from assessment through clinical review, pharmacy preparation and arrival. Nor does a structured shipping cadence identify the quantity supplied per charge. The terms additionally warn that prescription products will not be dispensed in child-resistant containers, an important practical detail for households where secure storage needs advance planning.
The reviewed documentation does not establish policies for lost packages, delays or temperature excursions. Ask who must be contacted, what information is required and whether replacements involve further charges. FDA explicitly advises not using injectable GLP-1 medication that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. A promise of temperature-controlled packaging is not a substitute for a documented response when the actual delivery raises concerns.
What does ongoing access mean in practice?
LongevityRx advertises direct messaging with the provider through a secure patient portal between scheduled check-ins. Its homepage says follow-ups are scheduled as needed so the plan can change over time. These are meaningful service features, but the public documentation does not establish a minimum consultation frequency, a clinician-message response standard or whether laboratory monitoring is required. Ask how clinical concerns are prioritized and how refill decisions connect to follow-up rather than assuming each payment includes a scheduled appointment.
The contact page lists support@startlongevityrx.com and (760) 493-6185, with clinical hours Monday through Friday, 9 a.m. to 5 p.m. The displayed block does not specify a time zone. Its contact form promises a team response within 24 hours; that is not a promise of clinical approval, medication arrival or a clinician’s response within the same period. Ask whether general support and clinical messaging have different response expectations, including outside those published hours.
The terms require a registered account with a username and password to access services. Before relying on that portal, clarify how to reach the medical team if login access fails and how to obtain prescription instructions from the pharmacy. FDA has received reports of compounded-medication measurement and administration errors, including some associated with hospitalization. Instructions should come from the prescriber or pharmacist, not from a review. Our follow-up support questions distinguish administrative access from clinical responsibility.
What should you clarify before uploading health information?
The treatment FAQ says LongevityRx is HIPAA compliant, that medical information is shared only with the assigned provider and dispensing pharmacy, and that it never sells or shares data. The terms provide a more qualified description: Cal Choice Family Practice, Inc says it is not a HIPAA covered entity, although it may act as a business associate of a pharmacy or medical group in certain circumstances. These descriptions require attention to which entity holds which information.
The California privacy notice adds that certain personal information may be made available to third parties for advertising measurement, delivery and more relevant content. It says those disclosures may constitute a sale or sharing under California law. This does not establish that medical records are sold, but it means the broad FAQ assurance should not be read as a complete account of all website data practices. Ask which categories and activities each statement covers.
Before completing an assessment, request the applicable medical privacy notice and ask how advertising preferences and privacy requests are handled. The California notice displays a different, placeholder-style telephone number from the published support number, so confirm a working channel rather than relying on it. This review did not examine the complete checkout, patient portal or HIPAA notice, and the available terms text omitted an intermediate section. Those limits prevent a full account of enrollment disclosures and data handling.
Questions & answers
Is LongevityRx’s $149 semaglutide price guaranteed?
No universal price is established. The homepage advertises injectable semaglutide from $149 per month and says pricing is confirmed after provider review. It also displays $249 without explaining that figure’s role. Ask for your approved recurring price, medication quantity and any separate required services before authorizing payment.
Will I be charged if I am not approved?
The homepage advertises no obligation and $0 if you are not approved. It also says treatment is not guaranteed and clinical decisions belong to licensed providers. That does not explain every payment-authorization step, so confirm when a card is charged and how the no-approval policy appears in checkout.
Can I cancel 48 hours before renewal?
The terms permit disabling auto-refill up to 48 hours before monthly processing, but treatment FAQs require 30 days’ notice before the next cycle. Obtain written clarification of the rule governing your purchase. Neither statement establishes a refund for services already begun or medication already processed.
Can I use my usual pharmacy?
The terms require prescription-inclusive purchases to use a pharmacy accessible through the platform and describe a waiver of choosing another pharmacy for that prescription. The pharmacy ships directly to you. Request its name and contact information before enrolling; the consulted documentation does not identify the partner pharmacies.
Does nationwide telehealth mean every state is covered?
Not necessarily. The terms restrict access to states where the company operates and require you to be physically in the same state as your shipping address during consultation. The reviewed pages do not establish a complete state list or product-specific availability. Confirm your state and any planned travel directly.
Is the Microdose program the same as the advertised injections?
The public documentation does not establish that. LongevityRx describes Microdose as a lower-dose GLP-1 protocol, but its active ingredient and route are not specified in the reviewed material. Its advertised goals and candidate descriptions are not evidence of demonstrated benefits. Ask for the exact proposed prescription and its clinical rationale.
Our assessment
LongevityRx documents a recognizable service offer: starting prices for compounded injectable semaglutide and tirzepatide, clinician review, bundled services, portal messaging and home delivery. Those details provide a useful starting point, but not a complete enrollment decision. The cancellation conflict deserves written resolution before payment, alongside confirmation of your actual price, supply quantity, treating entity, dispensing pharmacy and state availability. Privacy statements also need to be read together rather than relying on the FAQ alone. A practical next step is to request one written summary covering those points and the delivery-problem process, then compare that response with the terms presented at checkout.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- LongevityRx — treatments/glp 1 microdose ↗
- LongevityRx — official website ↗
- LongevityRx — treatments/semaglutide ↗
- LongevityRx — terms ↗
- LongevityRx — privacy ↗
- LongevityRx — contact ↗
- LongevityRx — treatments/tirzepatide ↗